San Francisco, United States
Osmind is a San Francisco–based public benefit corporation in the Health Care industry, founded in 2020. The company's mission, as stated in their slogan, is to become "The premier technology platform for breakthrough mental health treatment and research." Osmind is led by a team of scientists, technologists, and psychiatrists dedicated to advancing new evidence-generating medicine that benefits individuals dealing with moderate to severe mental health conditions.
The latest milestone for Osmind was a Series B investment of $40.00M secured on 10 May 2022. The notable investors participating in this funding round include Future Ventures, Gold House Ventures, Susa Ventures, AME Cloud Ventures, DFJ Growth, Tiger Global Management, WPSS.bio, Helena Goodman, Jeffrey Leiden, and Ariel Katz.
For those interested, Osmind is actively seeking new talent, as evidenced by their promotion of open positions and career opportunities on their website, osmind.org/careers.
For further details, individuals can visit osmind.org for additional information about the company and its initiatives.
